Mitochondrial dysfunction in peripheral blood mononuclear cells in early experimental and clinical acute pancreatitis

Pancreatology ◽  
2016 ◽  
Vol 16 (5) ◽  
pp. 739-747 ◽  
Author(s):  
Mandira Chakraborty ◽  
Anthony J.R. Hickey ◽  
Maxim S. Petrov ◽  
Julia R. Macdonald ◽  
Nichola Thompson ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
Mitochondrial Dysfunction ◽  
Peripheral Blood Mononuclear Cells ◽  
Peripheral Blood ◽  
Mononuclear Cells ◽  
Peripheral Blood Mononuclear ◽  
Blood Mononuclear Cells

scholarly journals Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells in Pediatric Septic Shock*

2015 ◽  
Vol 16 (1) ◽  
pp. e4-e12 ◽  
Author(s):  
Scott L. Weiss ◽  
Mary A. Selak ◽  
Florin Tuluc ◽  
Jose Perales Villarroel ◽  
Vinay M. Nadkarni ◽  
...  
Keyword(s):  
Septic Shock ◽  
Mitochondrial Dysfunction ◽  
Peripheral Blood Mononuclear Cells ◽  
Peripheral Blood ◽  
Mononuclear Cells ◽  
Peripheral Blood Mononuclear ◽  
Blood Mononuclear Cells

scholarly journals Peripheral Blood Mononuclear Cells and Platelets Mitochondrial Dysfunction, Oxidative Stress, and Circulating mtDNA in Cardiovascular Diseases

2020 ◽  
Vol 9 (2) ◽  
pp. 311 ◽  
Author(s):  
Abrar Alfatni ◽  
Marianne Riou ◽  
Anne-Laure Charles ◽  
Alain Meyer ◽  
Cindy Barnig ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Cardiovascular Diseases ◽  
Mitochondrial Dysfunction ◽  
Peripheral Blood Mononuclear Cells ◽  
Peripheral Blood ◽  
Mononuclear Cells ◽  
Oxidative Capacity ◽  
Ros Production ◽  
Peripheral Blood Mononuclear ◽  
Blood Mononuclear Cells

Cardiovascular diseases (CVDs) are devastating disorders and the leading cause of mortality worldwide. The pathophysiology of cardiovascular diseases is complex and multifactorial and, in the past years, mitochondrial dysfunction and excessive production of reactive oxygen species (ROS) have gained growing attention. Indeed, CVDs can be considered as a systemic alteration, and understanding the eventual implication of circulating blood cells peripheral blood mononuclear cells (PBMCs) and or platelets, and particularly their mitochondrial function, ROS production, and mitochondrial DNA (mtDNA) releases in patients with cardiac impairments, appears worthwhile. Interestingly, reports consistently demonstrate a reduced mitochondrial respiratory chain oxidative capacity related to the degree of CVD severity and to an increased ROS production by PBMCs. Further, circulating mtDNA level was generally modified in such patients. These data are critical steps in term of cardiac disease comprehension and further studies are warranted to challenge the possible adjunct of PBMCs’ and platelets’ mitochondrial dysfunction, oxidative stress, and circulating mtDNA as biomarkers of CVD diagnosis and prognosis. This new approach might also allow further interesting therapeutic developments.

Sign in / Sign up

Export Citation Format

Share Document